The UK’s National Institute for Health and Clinical Excellence (NICE) has published new medical technology guidance supporting a device that aims to help improve the treatment of wounds.
A newly published, prospective, randomised, comparative study suggests that diabetic foot ulcers are mostly healed with the application of MiMedx’s EpiFix allograft. And it seems weekly application speeds things up compared with bi-weekly.
Regenerative medicine company Acell, Inc., has announced the launch of its new MatriStem® Multilayer Wound Matrix device for deep, hard-to-heal, full-thickness wounds.
UK wound healing expert company Tissue Regenix is planning to launch its biological scaffold product, DermaPure™, in early 2014 and is putting in place an extensive distribution network to make sure it gains appropriate coverage.
The US FDA has cleared V.A.C.®Via™ Negative Pressure Wound Therapy System from Kinetic Concepts, Inc., featuring a diaphragm pump for faster draw down, longer battery life and higher leak rate threshold than its forebear.
Bruin Biometrics, LLC has gained CE Mark approval to market the SEM Scanner in the European Union. The SEM Scanner is that is intended to detect localized tissue edema and pressure induced tissue damage that may lead to the formation of pressure ulcers before damage becomes visible on the skin’s surface.
KCI is bringing together recently acquired Systagenix and LifeCell to form what it calls one “globally diversified wound care, biologics and … continue reading “KCI, LifeCell and Systagenix Combine Into One “Transformational Healing Solutions” Company”
Smith & Nephew says the US launch of its broad-spectrum antimicrobial DURAFIBER Ag dressing provides clinicians with a different approach to address bacterial contamination posed by medium to heavily exuding wounds.
Osiris Therapeutics, Inc., has reported results from its multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Grafix® to standard of care in patients with chronic diabetic foot ulcers. The Grafix group met the pre-specified stopping rules for overwhelming efficacy as determined by the data monitoring committee during a planned interim analysis.
Cardium Therapeutics has filed a new 510(k) submission for its current FDA-cleared Excellagen® advanced wound care product to reflect additional and specific structural and functional properties of the product.
Smith & Nephew plc has announced its results for the second quarter ended 29 June 2013 and the revenue growth … continue reading “Smith & Nephew Results Hold Up Despite Joint Pain”
Kinetic Concepts, Inc.(KCI) is to acquire UK-based Systagenix, an established provider of advanced wound care (AWC) products, for a purchase … continue reading “KCI in Full Growth Mode with Systagenix Acquisition”
We spotted a piece in Jewish Business News covering the tale of an Israeli firm which has developed a method … continue reading “Another New Technology Promises End For Staples And Stitches”
Biomaterials company MiMedx Group, Inc. an integrated developer, manufacturer and marketer of products processed from human amniotic membrane, has announced … continue reading “MiMedx EpiFix® Wound Care Allograft Trial Published”
Devon Medical, Inc. has received the CE mark for its portable extriCARE® 2400 Negative Pressure Wound Therapy (NPWT) system. NPWT has … continue reading “CE Mark For Devon Medical’s extriCARE® Portable Negative Pressure Wound Therapy System”
Smith & Nephew has revealed in-vitro study results suggesting ACTICOAT Silver-Coated Antimicrobial Dressings are bactericidal against some antibiotic resistant organisms carrying the NDM-1 enzyme, often referred to as ‘superbugs’.